Left ventricular thrombus in a patient with recurrent ischemic stroke events-The role of echocardiography.
cardiac magnetic resonance
cardiomyopathies
echocardiogram
left ventricular thrombus
stroke
Journal
Clinical case reports
ISSN: 2050-0904
Titre abrégé: Clin Case Rep
Pays: England
ID NLM: 101620385
Informations de publication
Date de publication:
May 2023
May 2023
Historique:
received:
13
02
2023
revised:
05
04
2023
accepted:
17
04
2023
medline:
5
5
2023
pubmed:
5
5
2023
entrez:
5
5
2023
Statut:
epublish
Résumé
Cardiac ultrasound is recommended in investigating ischemic stroke events. There is increasing evidence that direct oral anticoagulants can be safely used instead of vitamin K antagonists in the setting of left ventricular thrombus. Cardioembolic stroke is responsible for an increasing number of ischemic strokes. Compared to other causes of stroke, cardioembolic strokes affect a larger brain area. Left ventricular (LV) thrombi account for up to 10% of cardioembolic strokes. It is essential to identify patients at high risk of LV thrombus formation, such as patients with a history of myocardial infarction, patients with reduced ejection fraction, or patients with cardiomyopathies. We present a patient with an ischemic stroke, and the cardiac ultrasound revealed a reduced ejection fraction and the presence of LV thrombus at the apex. The patient had no prior history of cardiovascular diseases. Even in a resource-limited setting, cardiac ultrasound is recommended to investigate stroke or transient ischemic attack events, especially in patients with a prior history of myocardial infarction. Although patients with LV thrombus should be treated with oral anticoagulants for at least 3 months, the role of direct oral anticoagulants and the optimal period of anticoagulation in this setting needs further investigation.
Identifiants
pubmed: 37143461
doi: 10.1002/ccr3.7300
pii: CCR37300
pmc: PMC10151600
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e7300Informations de copyright
© 2023 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.
Références
J Cardiovasc Electrophysiol. 2021 Jun;32(6):1764-1771
pubmed: 33772939
Eur J Echocardiogr. 2010 Jul;11(6):461-76
pubmed: 20702884
Cardiovasc Revasc Med. 2022 Feb;35:141-146
pubmed: 33722539
Eur J Radiol. 2012 Dec;81(12):3900-4
pubmed: 22995173
Stroke. 2021 Jul;52(7):e364-e467
pubmed: 34024117
PLoS One. 2021 Jun 4;16(6):e0252549
pubmed: 34086768
J Ultrasound Med. 2014 Aug;33(8):1337-44
pubmed: 25063398
Am J Cardiol. 2013 Mar 1;111(5):667-70
pubmed: 23261006
J Cardiovasc Magn Reson. 2018 Nov 8;20(1):72
pubmed: 30404623
Expert Rev Cardiovasc Ther. 2021 May;19(5):427-432
pubmed: 33830867
Circ Res. 2017 Feb 3;120(3):514-526
pubmed: 28154101
J Am Coll Cardiol. 2022 Mar 15;79(10):1010-1022
pubmed: 35272796
Eur Heart J. 2018 Jan 7;39(2):119-177
pubmed: 28886621
Acta Cardiol. 2021 Nov;76(9):933-942
pubmed: 33393861
Clin Res Cardiol. 2021 Nov;110(11):1697-1703
pubmed: 32920662
J Am Coll Cardiol. 2013 Jan 29;61(4):e78-e140
pubmed: 23256914
Chest. 2012 Feb;141(2 Suppl):e637S-e668S
pubmed: 22315274
Thromb J. 2020 Oct 29;18:29
pubmed: 33132763
Circulation. 2022 Oct 11;146(15):e205-e223
pubmed: 36106537